FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Agila Specialties Private etomidate injection Recall

etomidate injection, USP, 2 mg/mL, packaged in a) 20 mg/10 mL (2 mg/mL), 10 mL Single D…

Agila Specialties Private Ltd. · Bangalore, Karnataka, N/A

Risk level
Class II
Reported by FDA
Apr 16, 2014
Recall ID
D-1225-2014
Check your lot numberHow we source this data

Summary

Agila Specialties Private recalled etomidate injection starting Feb 14, 2014. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1225-2014 on Apr 16, 2014. Reason: Presence of Particulate Matter: Potential for small black particles to be present in individual vials, the potential for missing lot number and/or expiry date on the outer carton and the potential for illegible/missing lot number and expiry on individual vials. Status: Terminated.

Why it was recalled

Presence of Particulate Matter: Potential for small black particles to be present in individual vials, the potential for missing lot number and/or expiry date on the outer carton and the potential for illegible/missing lot number and expiry on individual vials.

Product description

etomidate injection, USP, 2 mg/mL, packaged in a) 20 mg/10 mL (2 mg/mL), 10 mL Single Dose Vials (NDC 0069-0006-02), 10 x 10 mL vials per carton (NDC 0069-0006-01) and b) 40 mg/20 mL (2 mg/mL) 20 mL Single Dose Vials (NDC 0069-0006-04), 10 x 20 mL vials per carton (NDC 0069-0006-03), Rx only, Distributed by Pfizer Labs; Division of Pfizer Inc., New York, NY 10017.

Lot numbers, UPCs & expiration codes

Lot #: a) 5000983, 5000986, Exp 08/14; 5001023, Exp 09/14; b) 5000927, 5000931, 5000936, 5000942, 06/14; 5001012, 5001040, Exp 09/14; 5001071, Exp 10/14

Where it was sold

Nationwide and Puerto Rico

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1225-2014
Classification
Class II
Status
Terminated
Recall initiated
Feb 14, 2014
FDA report date
Apr 16, 2014
Quantity
7919 cartons
Recall type
Voluntary: Firm initiated
Recalling firm
Agila Specialties Private Ltd.

Original FDA data

Every field from FDA enforcement report D-1225-2014, exactly as published.

Show all FDA fields
City
Bangalore, Karnataka
Status
Terminated
Country
India
Event ID
67580
Address
Sterile Product Division, Opp IIM,
Address (line 2)
Bilekahalli, Bannerghatta Road
Code information
Lot #: a) 5000983, 5000986, Exp 08/14; 5001023, Exp 09/14; b) 5000927, 5000931, 5000936, 5000942, 06/14; 5001012, 5001040, Exp 09/14; 5001071, Exp 10/14
Report date
Apr 16, 2014
Product type
Drugs
Recall number
D-1225-2014
Classification
Class II
Recalling firm
Agila Specialties Private Ltd.
Product quantity
7919 cartons
Termination date
Dec 3, 2015
Reason for recall
Presence of Particulate Matter: Potential for small black particles to be present in individual vials, the potential for missing lot number and/or expiry date on the outer carton and the potential for illegible/missing lot number and expiry on individual vials.
Voluntary / mandated
Voluntary: Firm initiated
Product description
etomidate injection, USP, 2 mg/mL, packaged in a) 20 mg/10 mL (2 mg/mL), 10 mL Single Dose Vials (NDC 0069-0006-02), 10 x 10 mL vials per carton (NDC 0069-0006-01) and b) 40 mg/20 mL (2 mg/mL) 20 mL Single Dose Vials (NDC 0069-0006-04), 10 x 20 mL vials per carton (NDC 0069-0006-03), Rx only, Distributed by Pfizer Labs; Division of Pfizer Inc., New York, NY 10017.
Distribution pattern
Nationwide and Puerto Rico
Recall initiation date
Feb 14, 2014
Initial firm notification
Letter
Center classification date
Apr 8, 2014

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1225-2014, published Apr 16, 2014. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls